BEST UNLIMITED TURBO LONG CERTIFICATE - ELI LILLY & CO | Market Closed - Borsa Italiana 16:04:59 2024-06-26 EDT | ||
| 16.99 EUR | 0.00% |
|
| Current month | +77.41% | ||
| 1 month | +100.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 16.99 | -1.34% |
| 24-06-25 | 17.22 | +7.02% |
| 24-06-24 | 16.09 | +3.34% |
| 24-06-21 | 15.57 | +0.32% |
| 24-06-20 | 15.52 | -4.90% |
Real-time Borsa Italiana
Last update June 26, 2024 at 04:04 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| S34179 | |
| ISIN | DE000SU9FM13 |
| Date issued | 2024-02-20 |
| Strike | 724.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.87 € |
|---|---|
| Lowest since issue | 1.8 € |
| Spread | 0.16 € |
| Spread % | 0.94% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- S34179 Certificat
